A Case Report of Recurrent Rheumatic Fever: Considerations and Comments

Document Type: Case Report

Authors

1 Interventional cardiologist, Atherosclerosis Prevention Research Center, Imam Reza Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Clinician Scientist of Cardiology, Pharmaceutical Research Division, Booali Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3 Cardiology Resident, Department, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Rheumatic fever (RF) is a prevalent healthcare problem in the developing countries. Recurrence of this disorder is often observed in childhood and adolescence. RF can mimic the presentations of infective endocarditis, and clinicians are not really familiar with this issue. Herein, we present a case of recurrent acute rheumatic fever in a patient suspicious of acute bacterial endocarditis due to her previous RF. Finally, she was definitively diagnosed and underwent valvular replacement surgery and received prophylaxis antibiotics besides regular follow-up

Keywords


  1. Rayamajhi A, Sharma D, Shakya U. Firstā€episode versus recurrent acute rheumatic fever: is it different? Pediatr Int. 2009; 51:269-75.
  2. Bhardwaj R, Kandoria A, Marwah R, Vaidya P, Singh B, Dhiman P, et al. Prevalence of rheumatic fever and rheumatic heart disease in rural population of Himachal a population based study. J Assoc Physicians India. 2012; 60:13-4.
  3. Murray RC, Chennupati SK. Chronic streptococcal and non-streptococcal pharyngitis. Infect Disord Drug Targets. 2012; 12:281-5.
  4. Esposito S, Bianchini S, Fastiggi M, Fumagalli M, Andreozzi L, Rigante D. Geoepidemiological hints about Streptococcus pyogenes strains in relationship with acute rheumatic fever. Autoimmun Rev. 2015; 14:616-21.
  5. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis. Circulation. 2009; 119:1541-51.
  6. Metzgar D, Zampolli A. The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker. Virulence. 2011; 2:402-12.
  7. Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Acute rheumatic fever and its consequences: a persistent threat to developing nations in the 21st century. Autoimmun Rev. 2009; 9:117-23.
  8. Toor D, Vohra H. Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease. Microbes Infect. 2012; 14:1111-7.
  9. World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 20 October-1 November 2001. Geneva: World Health Organization; 2004.
  10.  Carvalho SM, Dalben I, Corrente JE, Magalhães CS. Rheumatic fever presentation and outcome: a case-series report. Rev Bras Reumatol. 2012; 52:241-6.
  11.  Carapetis JR, Mayosi BM, Kaplan EL. Controlling rheumatic heart disease in developing countries. Cardiovascr J S Afr. 2006; 17:164-5.
  12.  Jones TD. The diagnosis of rheumatic fever. J Am Med Assoc. 1944; 126:481-4.
  13. Kadir IS, Barker TA, Clarke B, Denley H, Grötte GJ. Recurrent acute rheumatic fever: a forgotten diagnosis? Ann Thorac Surg. 2004; 78:699-701.
  14. Rémond MG, Coyle ME, Mills JE, Maguire GP. Approaches to improving adherence to secondary prophylaxis for rheumatic fever and rheumatic heart disease: a literature review with a global perspective. Cardiol Rev. 2016; 24:94-8.